Page last updated: 2024-08-16

phenylpropanolamine and Innate Inflammatory Response

phenylpropanolamine has been researched along with Innate Inflammatory Response in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jiang, YH; Kuo, HC; Liu, HT1
Chaumais, MC; Girerd, B; Guignabert, C; Günther, S; Humbert, M; Montani, D; O'Connell, C; Perrin, S; Savale, L; Simonneau, G; Sitbon, O1

Other Studies

2 other study(ies) available for phenylpropanolamine and Innate Inflammatory Response

ArticleYear
Increased serum adipokines implicate chronic inflammation in the pathogenesis of overactive bladder syndrome refractory to antimuscarinic therapy.
    PloS one, 2013, Volume: 8, Issue:10

    Topics: Adipokines; Adult; Aged; Benzhydryl Compounds; C-Reactive Protein; Case-Control Studies; Cresols; Drug Resistance; Female; Humans; Inflammation; Male; Middle Aged; Muscarinic Antagonists; Nerve Growth Factor; Phenylpropanolamine; Prospective Studies; Tolterodine Tartrate; Urinary Bladder, Overactive

2013
Nasal decongestant exposure in patients with pulmonary arterial hypertension: a pilot study.
    The European respiratory journal, 2015, Volume: 46, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Amines; Amphetamines; Case-Control Studies; Female; Humans; Hypertension, Pulmonary; Inflammation; Male; Middle Aged; Naphazoline; Nasal Decongestants; Oxymetazoline; Phenylpropanolamine; Pilot Projects; Pseudoephedrine; Young Adult

2015